Cystatin C reduces the in vitro formation of soluble Aβ1‐42 oligomers and protofibrils

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Scandinavian Journal of Clinical and Laboratory Investigation

• Publication date

  2007-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1080/00365510601009738PMID 17365997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hereditary cerebral hemorrhage with amyloidosis

  2020cited by this paper
• Cystatin C-Properties and use as diagnostic marker

  2006cited by this paper
• Unique Physicochemical Profile of β-Amyloid Peptide Variant Aβ1–40E22G Protofibrils: Conceivable Neuropathogen in Arctic Mutant Carriers

  2004cited by this paper
• Binding of cystatin C to Alzheimer’s amyloid β inhibits in vitro amyloid fibril formation

  2004influential reference
• Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.

  2004cited by this paper
• Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration.

  2004cited by this paper
• Prevention of Domain Swapping Inhibits Dimerization and Amyloid Fibril Formation of Cystatin C

  2004cited by this paper
• Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease

  2004cited by this paper
• Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.

  2004cited by this paper
• Amyloid -protein (A) assembly: A40 and A42 oligomerize through distinct pathways

  2003cited by this paper
• In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis*

  2003cited by this paper
• Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.

  2003cited by this paper
• Cystatin C colocalizes with amyloid‐β and coimmunoprecipitates with amyloid‐β precursor protein in sporadic inclusion‐body myositis muscles

  2003cited by this paper
• Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

  2003cited by this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cited by this paper
• A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.

  2002cited by this paper
• Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.

  2002cited by this paper
• Codeposition of Cystatin C with Amyloid‐β Protein in the Brain of Alzheimer Disease Patients

  2001cited by this paper
• The cystatin C polymorphism is not associated with early onset Alzheimer’s disease

  2001cited by this paper
• Elevation of cystatin C in susceptible neurons in Alzheimer's disease.

  2001cited by this paper
• Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques.

  2001cited by this paper
• Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer’s disease

  2001cited by this paper
• Hereditary cystatin C amyloid angiopathy

  2000cited by this paper
• A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease

  2000cited by this paper
• FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor.

  2000cited by this paper
• Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.

  2000cited by this paper
• Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons

  1999cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Instability of the Amyloidogenic Cystatin C Variant of Hereditary Cerebral Hemorrhage with Amyloidosis, Icelandic Type*

  1998cited by this paper
• Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

  1997cited by this paper
• Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

  1997cited by this paper
• Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils.

  1997cited by this paper
• The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease.

  1996cited by this paper
• The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type

  1996cited by this paper
• The interaction of beta 2‐microglobulin (β2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse β2m

  1995cited by this paper
• Co‐localization of β/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis

  1994cited by this paper
• Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly.

  1993cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Expression of cystatin C in rat, monkey and human brains.

  1993cited by this paper
• Comparison between the Icelandic and Dutch forms of hereditary cerebral amyloid angiopathy.

  1992cited by this paper
• Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to beta protein and cystatin C.

  1990cited by this paper
• The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20

  1989cited by this paper
• Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases

  1989cited by this paper
• Efficient production of native, biologically active human cystatin C by Escherichia coli

  1988cited by this paper
• Improvement and simplification of low‐background silver staining of proteins by using sodium dithionite

  1988cited by this paper
• Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C).

  1986cited by this paper
• Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system.

  1979cited by this paper
• Hereditary cerebral haemorrhage with amyloidosis.

  1972cited by this paper

• Influence of Alzheimer’s associated Aβ oligomers and oxidative stress on blood–brain barrier dysfunction

  2025cites this paper
• Copper interaction with cystatin C: effects on protein structure and oligomerization

  2024cites this paper
• Protein Interactome of Amyloid-β as a Therapeutic Target

  2023cites this paper
• Human cystatin C induces the disaggregation process of selected amyloid beta peptides: a structural and kinetic view

  2023cites this paper
• Cystatins: unravelling the biological implications for neuroprotection

  2023cites this paper
• Effect of Ovocystatin on Amyloid β 1-42 Aggregation—In Vitro Studies

  2023cites this paper
• Ovocystatin Induced Changes in Expression of Alzheimer’s Disease Relevant Proteins in APP/PS1 Transgenic Mice

  2022cites this paper
• Changes in Serum Cystatin C Levels and the Associations With Cognitive Function in Alzheimer's Disease Patients

  2022cites this paper
• Amyloid Protein Cross-Seeding Provides a New Perspective on Multiple Diseases In Vivo.

  2022cites this paper
• Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology

  2021cites this paper
• Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.

  2021cites this paper
• Beneficial effect of ovocystatin on the cognitive decline in APP/PS1 transgenic mice.

  2019cites this paper
• Neuroprotection mediated by cystatin C-loaded extracellular vesicles

  2019cites this paper
• The Functional Mammalian CRES (Cystatin-Related Epididymal Spermatogenic) Amyloid is Antiparallel β-Sheet Rich and Forms a Metastable Oligomer During Assembly

  2019cites this paper
• A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

  2018cites this paper
• Analysis of Aβ x-42 /Aβ x-40 and Tau upon siRNA-mediated downregulation of APOE, BIN1, PICALM, CLU, PRNP and CST3 in wildtype mouse primary neurons

  2018cites this paper
• Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome.

  2018cites this paper
• Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid

  2017cites this paper
• Characteristics of C‐terminal, β‐amyloid peptide binding fragment of neuroprotective protease inhibitor, cystatin C

  2017cites this paper
• Cross-interactions between the Alzheimer disease amyloid-β peptide and other amyloid proteins. A FURTHER ASPECT OF THE AMYLOID CASCADE HYPOTHESIS.

  2017influential citation
• A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation

  2017cites this paper
• SNPs in A&bgr; clearance proteins: Lower CSF A&bgr;1-42 levels and earlier onset of dementia in PD

  2017cites this paper
• Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis*

  2016influential citation
• Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients

  2016cites this paper
• Cystatin C Shifts APP Processing from Amyloid-β Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells

  2016cites this paper
• Cystatin-related epididymal spermatogenic subgroup members are part of an amyloid matrix and associated with extracellular vesicles in the mouse epididymal lumen.

  2016cites this paper
• Cystatin C in aging and in Alzheimer's disease.

  2016cites this paper
• Expression, purification, and characterization of human cystatin C monomers and oligomers.

  2016cites this paper
• Natural Modulators of Amyloid formation in Alzheimer's disease

  2016cites this paper
• Protein Folding and Aggregation: A Revisit of Basic Conception

  2015cites this paper
• Cystatin C is differentially involved in multiple system atrophy phenotypes

  2015cites this paper
• Plasma β‐amyloid 40 levels are positively associated with mortality risks in the elderly

  2015cites this paper
• Cystatin C is a disease‐associated protein subject to multiple regulation

  2015cites this paper
• Transthyretin-derived peptides as β-amyloid inhibitors.

  2014cites this paper
• Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C

  2014cites this paper
• Cystatin C and Alzheimer's Disease

  2014cites this paper
• Natural factors influencing the fibrillation and toxicity of Aβ

  2014cites this paper
• Methods for Studying and Structure–Function Relationships of Non-Fibrillar Protein Assemblies in Alzheimer's Disease and Related Disorders

  2014cites this paper
• Alterations of CSF Cystatin C Levels and Their Correlations with CSF Αβ40 and Αβ42 Levels in Patients with Alzheimer's Disease, Dementia with Lewy Bodies and the Atrophic Form of General Paresis

  2013influential citation
• Interaction between baicalein and amyloid- β fibrils studied by fluorescence spectroscopy

  2013cites this paper
• Molecular Mechanisms in Amyloid Disorders. Novel Treatment Options in Hereditary Cystatin C Amyloid Angiopathy.

  2013cites this paper
• Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology

  2012cites this paper
• Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders

  2012cites this paper
• Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy

  2012cites this paper
• Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants

  2012cites this paper
• Identification of Novel Fluid Biomarkers for Alzheimer's Disease

  2012cites this paper
• Meta-Analysis of the Cystatin C(CST3) Gene G73A Polymorphism and Susceptibility to Alzheimer's Disease

  2012cites this paper
• Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants

  2012cites this paper
• Cystatin C in Alzheimer's disease

  2012cites this paper
• In vitro assays measuring protection by proteins such as cystatin C of primary cortical neuronal and smooth muscle cells.

  2012cites this paper
• Proteomic research in psychiatry

  2011cites this paper
• Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

  2011cites this paper
• Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

  2011cites this paper
• Protective mechanisms by cystatin C in neurodegenerative diseases.

  2011cites this paper
• PROTEIN BIOMARKERS FOR AMYOTROPHIC LATERAL SCLEROSIS: CHARATERIZATION AND IMPLICATIONS FOR DISEASE PATHOGENESIS

  2011cites this paper
• Cystatin C Protects Neuronal Cells from Amyloid-β-induced Toxicity

  2010influential citation
• Plasma Cystatin C and Risk of Developing Alzheimer's Disease in Subjects with Mild Cognitive Impairment

  2010cites this paper
• Induction of Autophagy by Cystatin C: A Mechanism That Protects Murine Primary Cortical Neurons and Neuronal Cell Lines

  2010cites this paper
• Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls

  2010cites this paper
• Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy.

  2010cites this paper
• Production of Cystatin C Wild Type and Stabilized Mutants

  2010cites this paper
• Amyloid β-protein, Cystatin C and Cathepsin B as Biomarkers of Alzheimer's Disease

  2010cites this paper
• The CST3 BB Genotype and Low Cystatin C Cerebrospinal Fluid Levels are Associated with Dementia in Lewy Body Disease

  2010cites this paper
• Chaperon-mediated single molecular approach toward modulating Abeta peptide aggregation.

  2009cites this paper
• Neuroprotective peptides in Alzheimer's disease:structural characterization an affinity of ß-amyloid and human cystatin C peptides interactions

  2009cites this paper
• Binding epitopes and interaction structure of the neuroprotective protease inhibitor cystatin C with beta-amyloid revealed by proteolytic excision mass spectrometry and molecular docking simulation.

  2009cites this paper
• Complexes of Amyloid-β and Cystatin C in the Human Central Nervous System

  2009cites this paper
• Amyloids and Protein Aggregation-Analytical Methods

  2009cites this paper
• Reduced Levels of Amyloid-β-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients

  2009cites this paper
• Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders.

  2008cites this paper
• Proteomic strategies for analysis of cerebrospinal fluid in neurodegenerative disorders

  2008cites this paper
• Cystatin C: a potential target for Alzheimer’s treatment

  2008cites this paper
• A Novel Panel of Cerebrospinal Fluid Biomarkers for the Differential Diagnosis of Alzheimer’s Disease versus Normal Aging and Frontotemporal Dementia

  2007cites this paper
• Domain swapping as a molecular mechanism in amyloidosis

  2007cites this paper
• Identification of a beta-amyloid-binding plasma protein, LRP1: implications for biomarker research and therapy in Alzheimer's disease.

  2007cites this paper
• Cystatin C modulates cerebral β-amyloidosis

  2007cites this paper
• Cystatin C modulates cerebral beta-amyloidosis.

  2007cites this paper
• List of papers

  1995cites this paper